Alembic Pharmaceuticals Limited

APLLTD.BO·BSE·Healthcare
Compare
895.75−11.45 (−1.26%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close907.20
Open919.05
Day range886.15936.25
52-week range635.30964.85
Off day high−4.33%
Off 52-week high−7.16%
Volume157.51K
Avg. volume (3M)21.35K
Market cap176.07B
EPS (TTM)42.93
Forward P/E18.30
P/E ratio (TTM)20.87
Dividend yield1.32% (12.00)
Beta (5Y)0.34
Shares outstanding196.56M
Short interest—
Earnings dateAug 6, 2025 (est.)
Analyst target961.80
Profit margin8.91%

Against its peers

Compare in full ›
APLLTD.BO ASTRAZEN.NS ALKEM.NS AUROPHARMA.NS AKUMS.BO GRANULES.BO
Market cap 176.07B 157.35B 620.54B 1.03T 114.04B 192.80B
P/E (TTM) 20.9 92.8 28.8 25.8 31.3 35.3
Forward P/E 18.3 — 23.2 19.0 21.8 26.5
Price/book 3.0 18.0 4.5 2.7 3.3 4.8
Dividend yield 1.32% 0.57% 0.38% — 0.13% 0.26%
1-year change −16.24% −30.90% −7.56% +47.46% +65.09% +0.63%
Today −1.26% −1.16% −0.51% +4.53% −0.76% −0.01%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

EquityBulls··2 outletsPositive

Alembic Pharmaceuticals Ltd receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%.

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ciprofloxacin and Dexamethasone Otic Suspension USP,…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance